EGFR and non-small cell lung carcinoma: We previously reported that 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], an active metabolite of vitamin D, is uniquely suitable for applications in EGFR-mutant NSCLC (Upadhyay et al., 2013).